Micro-RNA-125a mediates the effects of hypomethylating agents in chronic myelomonocytic leukemia

BACKGROUND: Chronic myelomonocytic leukemia (CMML) is an aggressive hematopoietic malignancy that arises from hematopoietic stem and progenitor cells (HSPCs). Patients with CMML are frequently treated with epigenetic therapeutic approaches, in particular the hypomethylating agents (HMAs), azacitidin...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Clin Epigenetics
Main Authors: Berg, Johannes Lorenz, Perfler, Bianca, Hatzl, Stefan, Mayer, Marie-Christina, Wurm, Sonja, Uhl, Barbara, Reinisch, Andreas, Klymiuk, Ingeborg, Tierling, Sascha, Pregartner, Gudrun, Bachmaier, Gerhard, Berghold, Andrea, Geissler, Klaus, Pichler, Martin, Hoefler, Gerald, Strobl, Herbert, Wölfler, Albert, Sill, Heinz, Zebisch, Armin
Formato: Artigo
Idioma:Inglês
Publicado em: BioMed Central 2021
Assuntos:
Research
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7789782/
https://ncbi.nlm.nih.gov/pubmed/33407852
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13148-020-00979-2
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados